A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation ¡ª published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciences¡ªis a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: Medicine is the practice of the diagnosis, treatment, and prevention of disease. With the advances in medical science, human beings are getting both longer life spans and higher quality of life. From herbs to molecular signatures, humankind is experiencing a transition from traditional medicine to personalized medicine: the right treatment to the right patient at the right time. However, it is not so easy to achieve this goal because the etiology of most diseases and disorders is still unclear. From description to association, numerous researchers are working together to decipher the mechanisms behind disease. To address such challenges, more and more global collaborations are badly needed to include experts from all disciplines: not just doctors, scientists and administration staff, but also engineers, technicians and marketing managers. Not limited to a fish-eye view, we humans should widen our vision and get more deep insights beyond the human community. That is the right way to assure sustainable healthcare for humanity.
  Related comments
Add comment (English only)
Name*:  
E-mail:  
Telephone:  
Code:    
Comments*:
Position: Home > issue > May 10, 2022 Volume 3, Issue 3
Omicron XE emerges as SARS-CoV-2 keeps evolving
Category:   News & Buzz   Download:  PDF  Figure  Endnote
Author: Kewei Ma, Jieliang Chen

52.jpg

Emerging SARS-CoV-2 variants of concerns and the newly designated recombinant lineage Omicron XE


Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019, the causative agent of coronavirus disease 2019 (COVID-19), the virus keeps evolving as transmission continues globally. On November 26, 2021, a highly divergent variant with a high number of mutations, the Omicron (PANGO lineage B1.1.529),1 was designated by the World Health Organization (WHO) as a variant of concern (VOC). The Omicron variant has been spreading rapidly than any other previous variants of SARS-CoV-2, and is currently the dominant variant worldwide that accounts for more than 95% of sequenced cases submitted to GISAID.





Host
ISSN 2666-6758
Publishing partner
Journal links
 
Academic co-partner
SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
INSTITUTE OF MICROBIOLOGY, CAS
XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
 
Collections

Air Pollution
Astronomy
Cancer
Chemistry & Materials
COVID-19
Environment Changes
Geoscience
Life Science & Medicine
Physics
ScienceX / Interdiscipline

 
Stay connected
  the.innovation.journal
  the.innovation.journal
  The Innovation
  TheInnovation´´ÐÂ
  TheInnovation´´ÐÂ
  The_Innovation
  office@the-innovation.org

Official£º@The_InnovationJ
Astronomy£º@TheInnovationA3
Chemistry£º@InnovationChem
Geoscience£º@TheInnovationG2
Informatics£º@Innovation_inf
Life Science£º@InnovationLS
Management£º@TheInnovationM1
Materials£º@TheInnovationM2
Medicine£º@Theinnovation_m
Physics£º@TheInnovationP1
ScienceX£º@TheInnovSciX

  Copyright © 2019-2022 Youth Innovation All Rights Reserved